Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections. (Q30358388)

21 August 2017

Vaccination of monoglycosylated hemagglutinin induces cross-strain protection against influenza virus infections. (English)

1 reference

21 August 2017

13

Chi-Huey Wong

1 reference

21 August 2017

Juine-Ruey Chen

1

1 reference

21 August 2017

Yueh-Hsiang Yu

2

1 reference

21 August 2017

Yung-Chieh Tseng

3

1 reference

21 August 2017

Wan-Ling Chiang

4

1 reference

21 August 2017

Ming-Feng Chiang

5

1 reference

21 August 2017

Yi-An Ko

6

1 reference

21 August 2017

Yi-Kai Chiu

7

1 reference

21 August 2017

Hsiu-Hua Ma

8

1 reference

21 August 2017

Chung-Yi Wu

9

1 reference

21 August 2017

Jia-Tsrong Jan

10

1 reference

21 August 2017

Kuo-I Lin

11

1 reference

21 August 2017

Che Ma

12

1 reference

21 August 2017

language of work or name

English

0 references

publication date

27 January 2014

1 reference

Proceedings of the National Academy of Sciences of the United States of America

21 August 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

21 August 2017

111

1 reference

21 August 2017

7

1 reference

21 August 2017

2476-2481

1 reference

Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Cross-neutralization of influenza A viruses mediated by a single antibody loop

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Highly Conserved Protective Epitopes on Influenza B Viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

A highly conserved neutralizing epitope on group 2 influenza A viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Vaccine design of hemagglutinin glycoprotein against influenza

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challenge

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Glycans on influenza hemagglutinin affect receptor binding and immune response

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Cross-protective potential of a novel monoclonal antibody directed against antigenic site B of the hemagglutinin of influenza A viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Antibody recognition of a highly conserved influenza virus epitope

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Vaccination and antigenic drift in influenza

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

The global circulation of seasonal influenza A (H3N2) viruses

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Effect of addition of new oligosaccharide chains to the globular head of influenza A/H2N2 virus haemagglutinin on the intracellular transport and biological activities of the molecule

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3932897

Restoration of virulence of escape mutants of H5 and H9 influenza viruses by their readaptation to mice

3 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24469815

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.1323954111

1 reference

21 August 2017

0 references

1 reference

21 August 2017

PubMed publication ID

24469815

1 reference